Bachem
More Content From Bachem
-
Bachem brings scientific expertise to Spring 2024 conferences
Bachem will use all three events to showcase its leading-edge capabilities as a peptide and oligonucleotide manufacturer.News Releases Released on 03.15.2024
-
No More DMF: Greener Solid-Phase Peptide Synthesis With Binary Solvents [WATCH ON-DEMAND]
Learn how the polarity and viscosity profiles of binary solvents can be used to predict their utility for producing different peptides by SPPS.Sponsored Content Released on 12.01.2023
-
[WEBINAR] Large-Scale TIDES Purification With MCSGP Under GMP
Join Bachem for a Virtual Event on Tuesday, December 5th, 2023.News Releases Released on 11.22.2023
-
Back to Stirred Vessels and on to Metric Tons of Oligonucleotides
Scientists seek to discover new production routes when manufacturing limits arise.Sponsored Content Released on 11.22.2023
-
Leading the Octreotide Scale-Up - A Generics Case Study
Bachem Develops a Cost-Effective, Large-Batch Process for Octreotide Acetate SynthesisCase Studies Released on 11.08.2023
-
[WEBINAR] Tag-assisted one-pot liquid-phase oligonucleotide synthesis
The webinar will take place on November 15, 2023 at 11:00 AM ET / 8:00 AM PT / 17:00 CETNews Releases Released on 11.08.2023
-
Visit Bachem at CPhI Worldwide 2023
Bachem is participating in this global event and invite you to be inspired by their innovative and sustainable approaches to generic API manufacturing.News Releases Released on 10.05.2023
-
Peptide Aggregation – A Complex Topic [WATCH ON-DEMAND]
Bachem's experts share their analytical expertise on peptide aggregation and how to avoid it through optimized downstream process conditions.Sponsored Content Released on 10.02.2023
-
High-Resolution Mass Spectrometry of Oligonucleotides – Characterization Made Easy [WATCH ON-DEMAND]
Direct, robust and easy-to-use techniques to fully characterize the nucleotide sequence of highly modified single-stranded RNAs by top down tandem MS.Sponsored Content Released on 09.01.2023
-
Learn About Methods for Making Long and Complex Peptides
The pros and cons of today’s technologies for SPPS, native chemical ligation, CEPS, KAHA and recombinant technologies.Sponsored Content Released on 08.16.2023
-
Scalable Oligonucleotide Manufacture with Stirred-Bed Technology [WATCH ON-DEMAND]
Learn how to reach commercial oligonucleotides API production in metric ton range with unbeaten process mass intensity and much more.Sponsored Content Released on 08.04.2023
-
Solid Phase Peptide Synthesis Explained
Solid phase peptide synthesis (SPPS) is a technique for peptide synthesis.Sponsored Content Released on 06.28.2023
-
Manufacturing Complex Peptide APIs
An interview with Sergey Malashikhin of Bachem on what’s behind the manufacturing of complex APIs.Sponsored Content Released on 05.31.2023
-
Peptide Aggregation - A Complex Topic
In this webinar, Bachem's experts share their analytical expertise on peptide aggregation and how to avoid it through optimized downstream process conditions.News Releases Released on 05.31.2023
-
Purification – A Bottleneck for Large-Scale Manufacturing of Oligonucleotide API?
Continuous chromatography is a promising solution due to its high productivity, improved selectivity, and reduced costs.Sponsored Content Released on 05.31.2023
Related Content
-
Bachem reports excellent results for the first half-year 2021
Sales of CHF 500 million are now expected for the year 2021.
-
Bachem and Novo Nordisk Redesign SPPS for Green Chemistry
Replacing gold standard solvents to provide a greener alternative.
-
APIs
Propofol – A Bachem Success Story
The COVID-19 pandemic has rapidly expanded awareness of the API Propofol, produced by Bachem in Vionnaz.
-
Bachem News & Events
Learn more about what is happening at Bachem, what activities we have coming up, and what events you can meet us both virtually and in-person.
-
Bachem Capabilities to Address the New FDA Guideline for Synthetic Peptides
Scientific and regulatory challenges remain a big hurdle on the way to successful approval of generic drugs falling under this guideline.
-
Take Off With Bachem - A Step Into The Future
The Swiss based Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
-
APIs
Generic APIs Portfolio
With almost 50 years of expertise in peptide and small molecule synthesis, Bachem has an outstanding track record in large-scale manufacturing.
-
Customer Testimonial - Yuyu Pharma
Robert Yu, CEO of Yuyu Pharma, discussed his experience working with Bachem.
-
Customer Testimonial - Luye Pharma
Amy Zang, Head of Supply Chain at Luye Pharman spoke with us about her experience working with Bachem.
-
Biologics, Proteins, Vaccines | Breaking News | Capsules | Cold Chain Management | Drug Delivery | Formulation Development | Industry News | Solid Dosage/Semi-solids | Supply Chain | Vials
Catalent Awarded Grant Under Vaccine Research Consortium
Will evaluate Zydis Technology to develop thermo stable and cold-chain independent vaccines04.21.15
-
APIs | Chemistry | Process Development | Risk Management | Supply Chain
Pharmaceutical Fine Chemicals…Quo Vadit?
Captive and merchant demand estimated at $80 billion and growing 4-5% per annum.Dr. Enrico T. Polastro , Arthur D. Little 01.29.15
-
Breaking News | Capsules | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Industry News | Lyophilization | Process Development
Biodel, Emergent BioSolutions Enter Glucagon Mfg. Pact
To provide fill/finish of commercial quantities for GEM deviceKristin Brooks 03.06.14
-
Bio News | Biosimilars | Promotions & Moves
